136 related articles for article (PubMed ID: 6426381)
1. In vitro antibacterial activity of cefpiramide.
Pfaller MA; Niles AC; Murray PR
Antimicrob Agents Chemother; 1984 Mar; 25(3):368-72. PubMed ID: 6426381
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC
Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
Hoogkamp-Korstanje JA; Meijer CA
Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
[TBL] [Abstract][Full Text] [Related]
5. The in vitro activity and beta-lactamase stability of cefpiramide compared with other beta-lactam antibiotics.
Neu HC; Chin NX
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):479-88. PubMed ID: 3877607
[TBL] [Abstract][Full Text] [Related]
6. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
7. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Prince AS; Neu HC
Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China.
Wang H; Yu Y; Xie X; Wang C; Zhang Y; Yuan Y; Zhang X; Liu J; Wang P; Chen M
J Infect Chemother; 2000 Jun; 6(2):81-5. PubMed ID: 11810540
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of BRL 36650, a new penicillin.
Van Landuyt HW; Lambert A; Boelaert J; Gordts B
Antimicrob Agents Chemother; 1986 Feb; 29(2):362-6. PubMed ID: 3087281
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli.
Fass RJ; Helsel VL
Diagn Microbiol Infect Dis; 1986 Jan; 4(1):77-81. PubMed ID: 3943292
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
14. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Acred P; Ryan DM; Sowa MA; Watts CM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of cefpiramide, a new parenteral cephalosporin.
Quentin C; Noury P; Titonel M
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):544-9. PubMed ID: 3141169
[TBL] [Abstract][Full Text] [Related]
16. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.
Fukasawa M; Noguchi H; Okuda T; Komatsu T; Yano K
Antimicrob Agents Chemother; 1983 Feb; 23(2):195-200. PubMed ID: 6601470
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins.
Parry MF; Folta D
J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043
[TBL] [Abstract][Full Text] [Related]
19. Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
Tumah H
Chemotherapy; 2005 May; 51(2-3):80-5. PubMed ID: 15870501
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Norris SM; Guenthner SH; Wenzel RP
J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
